Wolf Theiss advised Ascend Capital Partners on the legal aspects of the investment in piur imaging, a Viennese startup focusing on tomographic 3D ultrasound solutions.
A multidisciplinary team led by M&A Partner Sarah Wared advised Ascend Capital Partners with respect to all legal aspects of the Series A financing from an Austrian law perspective (due diligence, advice in connection with the transaction agreements).
Founded in 2014, PIUR’s vision is to maximize access to safe and accurate image diagnostics through AI-driven tomographic ultrasound solutions. PIUR currently focuses on changing the way thyroid diagnostics is performed. With its Infinity system, high resolution ultrasound volumes of the thyroid can be generated and analyzed with AI-support, generating reproducible diagnostic results more efficiently.
Ascend Capital Partners is a leading international venture capital and financial advisory firm committed to working with innovative companies who have potential to grow and expand internationally, especially in Europe, China, and the United States. With extensive regional and international networks, and insight into Chinese and Western capital market worlds, Ascend has set itself apart from other pure advisory firms and pure private equity funds. For more information, please visit www.ascend-cp.com.
Members of the Wolf Theiss core team were in addition to Sarah Wared (Partner, Corporate | M&A) Jana Landhaeusser (Associate, Corporate | M&A) and Nikolaus Wollner (Associate, Corporate | M&A).